BioAmber Inc.
BIOA.WS
BIOA.WS was delisted on the 3rd of May, 2017.
11 hedge funds and large institutions have $3.61M invested in BioAmber Inc. in 2013 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.
8% less funds holding
Funds holding: 12 → 11 (-1)
12% less capital invested
Capital invested by funds: $4.1M → $3.61M (-$492K)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
+$9.69K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JGC
J. Goldman & Co
New York
|
-$96K |
| 2 |
Barclays
London,
United Kingdom
|
-$1 |
BIOA.WS Hedge Fund Activity: Q4 2013 in Review
11 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in BioAmber Inc. (BIOA.WS) for Q4 2013, worth a combined $3.61M — down 12% from $4.1M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of BIOA.WS and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $9.69K. The largest seller was J. Goldman & Co, exiting entirely with an estimated $96K sold.
- 11 institutional investors held BioAmber Inc. (BIOA.WS) as of Q4 2013, down from 12 in Q3 2013.
- Funds reported $3.61M of BioAmber Inc. stock for Q4 2013, down 12% quarter-over-quarter.
- 1 fund opened new BioAmber Inc. positions in Q4 2013 and 2 closed out, a net change of -1 holder.
- The largest BioAmber Inc. buyer in Q4 2013 was Virtu KCG Holdings, an estimated $9.69K added.
- The largest BioAmber Inc. seller in Q4 2013 was J. Goldman & Co, an estimated $96K sold.
Based on aggregated 13F filings for Q4 2013.